Sirui Ma, M.D. | Hematology & Oncology Faculty Recruitment Seminar

"Bispecific Antibodies in Large B-cell Lymphoma: Past Triumphs, Present Challenges, and Future Opportunities"

Speaker:

Sirui Ma, M.D.
Hematology & Oncology Fellow
University of California San Francisco

About Sirui Ma:

Dr. Ma holds bachelor's degrees in neuroscience and in religious studies from Vanderbilt University in Nashville, Tennessee. He earned his medical degree from Washington University in St. Louis and completed internal medicine residency training at Beth Israel Deaconess Medical Center in Boston.

Dr. Ma specializes in hematologic malignancies, with a particular focus on lymphoma. His clinical interests include diffuse large B-cell lymphoma, Richter transformation, and Hodgkin lymphoma, as well as the use of emerging immunotherapies and cellular therapies for patients with relapsed or refractory disease.

Dr. Ma's research focuses on improving outcomes for patients with lymphoma through clinical and translational studies of novel therapies. His work examines treatment response, immune-related toxicities, and patient selection for approaches such as bispecific antibodies, CAR T-cell therapy, and checkpoint inhibitors, with additional interests in frailty, thrombosis, infectious complications, and real-world outcomes across lymphoid malignancies. His research has contributed to a growing understanding of how newer immunotherapy-based strategies can be used more safely and effectively in lymphoma care.